Myokardia
South San Francisco, US · Founded 2012 · Delaware corporation · 3 known investors
Biotech
Founders & leadership
KS
Kevin StarrDirector
CH
Charles HomcyDirector
MP
Mark PerryDirector
KB
Katherine BowdishDirector
TA
Tassos Anastasios GianakakosExecutive Officer, Director
Investors · 3
Reported raises · per SEC filings
Form D private placements▶$46MraisedApr 2015 · 9 investors · BiotechnologyRule 506(b)
▶$46MraisedApr 2015 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Kevin StarrDirector
- Charles HomcyDirector
- Mark PerryDirector
- Katherine BowdishDirector
- Tassos Anastasios GianakakosExecutive Officer, Director
- Offering amount
- $46M
- Amount sold
- $46M
- First sale
- Apr 2015
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.